Status:
COMPLETED
Compare Two Anti-Scorpion Venom Serum In Children
Lead Sponsor:
Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.
Conditions:
Scorpion Sting
Eligibility:
All Genders
1-15 years
Phase:
PHASE3
Brief Summary
The morbidity associated with scorpion sting intoxication presents an endemic pattern in the country, where there are highly venomous species of scorpions so the scorpion sting intoxication (IPPA) is ...
Detailed Description
We consider relevant conduct this study because the poisoning scorpion bite represents a public health problem. This is a randomized clinical trial, which included 120 subjects of both sexes aged 0 a...
Eligibility Criteria
Inclusion
- Scorpion sting
- Either sex
- Age 1 to 15 years
- Signing an informed consent (signed by parent or guardian)
- Being residents of the state of Guanajuato
Exclusion
- Previous treatment with gamma globulin or immunoglobulin
- Blood transfusion at any stage of life
- Patients treated with drugs that interact with anti-scorpion serum
- History or history of sensitivity or intolerance to anti-scorpion serum or horse products
- Pregnancy
- Any immunodeficiency
- Patients who have participated in a research protocol in the previous month.
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01415830
Start Date
August 1 2011
End Date
May 1 2012
Last Update
February 7 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital General Regional de León
León, Guanajuato, Mexico, 37320